ebastine has been researched along with Liver Diseases in 1 studies
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Finally, no apparent difference was noted in the safety of ebastine between patients with hepatic insufficiency and healthy subjects as assessed by evaluation of adverse events, vital signs and laboratory parameters." | 2.71 | Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. ( Dilzer, SC; Lasseter, KC; Noveck, RJ; Vargas, R; Waldman, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lasseter, KC | 1 |
| Dilzer, SC | 1 |
| Vargas, R | 1 |
| Waldman, S | 1 |
| Noveck, RJ | 1 |
1 trial available for ebastine and Liver Diseases
| Article | Year |
|---|---|
Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
Topics: Adult; Area Under Curve; Butyrophenones; Case-Control Studies; Female; Half-Life; Histamine H1 Antag | 2004 |